Skip to main content
. Author manuscript; available in PMC: 2021 Nov 15.
Published in final edited form as: Clin Cancer Res. 2021 Mar 8;27(10):2920–2927. doi: 10.1158/1078-0432.CCR-20-4650

Figure 4:

Figure 4:

Genomic landscape of EGFR ex20ins. A. Oncoprint of the mutations and copy number alterations found at ≥5% frequency among ex20ins cases, with TMB quantified at top of graph B. Frequency of altered genes in EGFR ex20ins cohort compared to NSCLC without EGFR ex20ins. Genes highlighted in red designate q-value <0.05. C. Frequency of CNA in the EGFR ex20ins cohort compared to other NSCLC cases.